APPLIED GENETIC TECHNOLOGIES CORP
DelistedCIK 1273636fmd_1BDZRMWRBQDEMXR04S3VJVVEF8Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jul 01, 2011 to Sep 30, 2022, 42 periods
Latest annual · FY2022
Millions- Total revenues
- 0
- Operating income
- (66)
- Net income
- (69)
- Free cash flow
- (67)
Latest quarter · Q1 FY2023
Millions- Total revenues
- 0
- Operating income
- (17)
- Net income
- (18)
- Free cash flow
- (16)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- -80.2%
- Revenue, 5 yearsFY2017 to FY2022
- -61.7%
- Net income, 5 yearsFY2017 to FY2022
- n/m
APPLIED GENETIC TECHNOLOGIES CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $325,000 | $500,000 | -35% | 10-K 2022-09-27 · proof |
| Operating income | -$66.2 million | -$58.5 million | 10-K 2022-09-27 · proof | |
| Net income | -$68.9 million | -$57.8 million | 10-K 2022-09-27 · proof | |
| Cash from operating activities | -$65.7 million | -$51.2 million | 10-K 2022-09-27 · proof | |
| Free cash flow | -$67.4 million | -$52.6 million | 10-K 2022-09-27 · proof | |
| Total assets | $66.7 million | $127 million | -47.5% | 10-K 2022-09-27 · proof |
| Total liabilities | $37.2 million | $41.2 million | -9.6% | 10-K 2022-09-27 · proof |
| Cash and cash equivalents | $46.4 million | $105.1 million | -55.9% | 10-K 2022-09-27 · proof |
| Total debt | $18.4 million | $19.9 million | -7.5% | 10-K 2022-09-27 · proof |
- What was APPLIED GENETIC TECHNOLOGIES CORP's revenue in fiscal 2022?
- APPLIED GENETIC TECHNOLOGIES CORP reported revenue of $325,000 for fiscal 2022 (the year ended Jun 30, 2022), against $500,000 the year before (-35%). Source: the 10-K filed with the SEC on Sep 27, 2022. SEC
- What was APPLIED GENETIC TECHNOLOGIES CORP's operating income in fiscal 2022?
- APPLIED GENETIC TECHNOLOGIES CORP reported operating income of -$66.2 million for fiscal 2022 (the year ended Jun 30, 2022), against -$58.5 million the year before. Source: the 10-K filed with the SEC on Sep 27, 2022. SEC
- What was APPLIED GENETIC TECHNOLOGIES CORP's net income in fiscal 2022?
- APPLIED GENETIC TECHNOLOGIES CORP reported net income of -$68.9 million for fiscal 2022 (the year ended Jun 30, 2022), against -$57.8 million the year before. Source: the 10-K filed with the SEC on Sep 27, 2022. SEC
- What was APPLIED GENETIC TECHNOLOGIES CORP's cash from operating activities in fiscal 2022?
- APPLIED GENETIC TECHNOLOGIES CORP reported cash from operating activities of -$65.7 million for fiscal 2022 (the year ended Jun 30, 2022), against -$51.2 million the year before. Source: the 10-K filed with the SEC on Sep 27, 2022. SEC
- What was APPLIED GENETIC TECHNOLOGIES CORP's free cash flow in fiscal 2022?
- APPLIED GENETIC TECHNOLOGIES CORP reported free cash flow of -$67.4 million for fiscal 2022 (the year ended Jun 30, 2022), against -$52.6 million the year before. Source: the 10-K filed with the SEC on Sep 27, 2022. SEC
- What are APPLIED GENETIC TECHNOLOGIES CORP's total assets?
- As of Jun 30, 2022, APPLIED GENETIC TECHNOLOGIES CORP reported total assets of $66.7 million, against $127 million a year earlier (-47.5%). Source: the 10-K filed with the SEC on Sep 27, 2022. SEC
- What are APPLIED GENETIC TECHNOLOGIES CORP's total liabilities?
- As of Jun 30, 2022, APPLIED GENETIC TECHNOLOGIES CORP reported total liabilities of $37.2 million, against $41.2 million a year earlier (-9.6%). Source: the 10-K filed with the SEC on Sep 27, 2022. SEC
- What are APPLIED GENETIC TECHNOLOGIES CORP's cash and cash equivalents?
- As of Jun 30, 2022, APPLIED GENETIC TECHNOLOGIES CORP reported cash and cash equivalents of $46.4 million, against $105.1 million a year earlier (-55.9%). Source: the 10-K filed with the SEC on Sep 27, 2022. SEC
- What is APPLIED GENETIC TECHNOLOGIES CORP's total debt?
- As of Jun 30, 2022, APPLIED GENETIC TECHNOLOGIES CORP reported total debt of $18.4 million, against $19.9 million a year earlier (-7.5%). Source: the 10-K filed with the SEC on Sep 27, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1273636&period_type=annual&limit=5"Information only, not investment advice.